Bide Pharmatech Management
Management criteria checks 0/4
Bide Pharmatech's CEO is Lan Dai, appointed in Oct 2023, has a tenure of 1.08 years. directly owns 33.58% of the company’s shares, worth CN¥1.37B. The average tenure of the management team and the board of directors is 1.1 years and 1.1 years respectively.
Key information
Lan Dai
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.1yrs |
CEO ownership | 33.6% |
Management average tenure | 1.1yrs |
Board average tenure | 1.1yrs |
CEO
Lan Dai (52 yo)
1.1yrs
Tenure
Ms. Lan Dai is GM & Chairman of Bide Pharmatech Co. Ltd. from October 13, 2023. Ms. Dai was Director of Bide Pharmatech Co. Ltd.from October 17, 2020 to October 13, 2023.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Chairman | 1.1yrs | no data | 33.58% CN¥ 1.4b | |
Secretary of the Board | 5.1yrs | CN¥982.10k | no data | |
Deputy GM & Director | no data | CN¥928.00k | no data | |
Assistant to GM & Director | 1.1yrs | CN¥898.00k | no data | |
Senior Product Manager | no data | no data | no data |
1.1yrs
Average Tenure
41yo
Average Age
Experienced Management: 688073's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Chairman | 4.1yrs | no data | 33.58% CN¥ 1.4b | |
Secretary of the Board | 1.1yrs | CN¥982.10k | no data | |
Deputy GM & Director | 4.1yrs | CN¥928.00k | no data | |
Assistant to GM & Director | 1.1yrs | CN¥898.00k | no data | |
Independent Director | 1.1yrs | CN¥19.40k | no data | |
Supervisor | 4.1yrs | no data | no data | |
R&D Director and Supervisor | 4.1yrs | CN¥549.90k | no data | |
Independent Director | 1.1yrs | CN¥19.40k | no data | |
Independent Director | 1.1yrs | CN¥19.40k | no data | |
Brand Senior Director & Supervisor | 1.1yrs | CN¥712.60k | no data |
1.1yrs
Average Tenure
42.5yo
Average Age
Experienced Board: 688073's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.